|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
450 East 29th Street,New York,NY,US
|
|
Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.Our late-stage product candidate, belumosudil, is an orally administered selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2) in development for the treatment of inflammatory and fibrotic diseases. A pivotal study of belumosudil is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 study in systemic sclerosis. Kadmon is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. Our lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein in a Phase 1 clinical trial.
|
Kadmon Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
76.47%
|
The widely used Kadmon email format is {first}.{last} (e.g. [email protected]) with 76.47% adoption across the company.
To contact Kadmon customer service number call here 833-900-5366. To contact Kadmon customer service number in your country click here to find.
Zeevik Brin is the CEO of Kadmon. To contact Zeevik Brin email at [email protected]. Or you may call +972545596666
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.